Motley Fool•3 days agoCRISPR Therapeutics Stock Is Up Only 8% This Year. Is Cathie Wood's Bet on the Gene-Editing Stock Dead Money?
Motley Fool•9 days agoWhich Is the Better Short-Term Bond ETF, Vanguard's VTES or VanEck's SMB?^GSPC0.28%